Nrc Health vs Omniab
Nrc Health (NRC) and Omniab (OABI) side by side: how big they are, what they earn, how their shares have moved and what insiders, members of Congress and funds reported. Figures from filings and closing prices; none of this is a view on either stock.
- Market value
- $534M
- Last close
- $25.16
- 12 months
- +51.5%
- Market value
- $680M
- Last close
- $4.66
- 12 months
- +179.0%
At a glance
- The biggest part of Omniab's revenue is License and milestone revenue, 52% of the total in its last annual report.
- By market value, Omniab ($680M) is about 1.3 times Nrc Health ($534M).
- Over the last 12 months Nrc Health's share price moved +51.5% and Omniab's +179.0%; against the S&P 500 that is +45.8 points and +173.3 points.
- In the last 90 days insiders reported 0 open-market purchases at Nrc Health and 0 at Omniab; members of Congress disclosed 0 trades in Nrc Health and 0 in Omniab.
- Next results: Nrc Health Feb 1, 2027, Omniab Mar 2, 2027.
How each one makes money: Omniab revenue
Share prices on one chart
Nrc Health and Omniab, and up to three more you add, drawn on the same scale so you can see which moved more.
Face to face
The figures that separate the two, drawn to the same scale. Every figure is also in the table below.
Size
Market value
Revenue, last fiscal year
Net income, last fiscal year
Every figure
| Nrc Health NRCNASDAQ · Services-Commercial Physical & Biological Research | Omniab OABINASDAQ · Services-Commercial Physical & Biological Research | |
|---|---|---|
| Size and profitability | ||
| Market value | $534M | $680M |
| Revenue, last fiscal year | $137M | $18.7M |
| Net income, last fiscal year | — | −$64.8M |
| Net marginNet income as a share of revenue | — | -347.0% |
| Free cash flow | $15.7M | |
Prices are end-of-day closes, and fundamentals are the companies' last annual figures from their SEC filings: a − or + in the table is a fact of the filing or the close, not a forecast. Market value is the company-level figure at the last close. Counts are of records OQRO holds, by their date; insider history since 2006 comes from the SEC's insider transactions data sets and every filing since. Planned sales under a 10b5-1 plan are counted like other sales.
Common questions
How is Nrc Health different from Omniab?
Nrc Health (NRC) is in Services-Commercial Physical & Biological Research on NASDAQ, with $137M of revenue in its last fiscal year. Omniab (OABI) is in Services-Commercial Physical & Biological Research on NASDAQ, with $18.7M of revenue in its last fiscal year and a net margin of -347.0%. The biggest part of Omniab's revenue is License and milestone revenue, 52% of the total in its last annual report. The table above sets their figures side by side; it compares filings and is not a view on either stock.
How do Nrc Health and Omniab compare in size?
Omniab has the larger market value: Nrc Health $534M and Omniab $680M, at the last close.
Whose share price rose more over the last 12 months, NRC or OABI?
Over the last 12 months Nrc Health moved +51.5% and Omniab +179.0%. Past price moves say nothing about the future.
Which has had more insider buying, Nrc Health or Omniab?
Both have the same number of open-market insider purchases since 2006 (21).
Do members of Congress trade NRC or OABI?
In the last 12 months, members of Congress disclosed 0 trades in Nrc Health (NRC) and 0 in Omniab (OABI).
When did insiders last buy NRC and OABI?
Nrc Health: Feb 19, 2026. Omniab: May 15, 2025.
See the record behind any of these
A free account opens the full history of every insider and company since 2006, the screener, alerts, Congress trades and fund moves.
Nrc Health pageOmniab pageRare insider trades this weekAll comparisons
https://oqro.io/compare/nrc-vs-oabi
